UNSPSC 51141522: Oxcarbazepine

This classification denotes an anticonvulsant agent with the molecular formula C15H12N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VZI5B1W380, chemically known as 10,11-dihydro-10-oxo-5h-dibenz(b,f)azepine-5-carboxamide but generally known as oxcarbazepine, which bears US NIH Compound Identifier 34312. European Medicines Agency schedules Oxcarbazepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09510MIG.

UNSPSC 51141522 Oxcarbazepine is a Commodity code for a specific anticonvulsant pharmaceutical product, but the recent state and local procurement activity recorded under this code does not align with oxcarbazepine acquisition. Instead, Seminole County, Florida has posted an IFB for naloxone (an opioid-reversal medication) and safe drug deactivation systems—products outside the scope of this code's nominal pharmaceutical classification. State and local procurement systems occasionally tag opportunities with codes that do not match the work being solicited; this code shows little relevant recent activity for oxcarbazepine itself.

Seminole County's June 2026 IFB 60459723LAS sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carried a two-year initial term with one-year renewal option, fixed-fee pricing, E-Verify and drug-free workplace compliance requirements, and potential FEMA funding with associated federal environmental compliance obligations. Without additional recent opportunities under this code supporting actual oxcarbazepine procurement, the activity signal is too thin to characterize issuing-body patterns or geographic concentration.